cell line to cGMP in 9 – 11 months
As you move out of the discovery phase and into clinical development, you will need an increase in the quantity and quality of your product. Our Light Path™ Mammalian Development Protein Production Service enables you to continue with Lonza for scale-up and cGMP manufacture of your protein or antibody for preclinical studies through early phase clinical development. Research access to our GS Xceed® Mammalian Expression System is available with no license fee while the work is performed at a Lonza facility.
Mammalian Development Offering Includes:
- Optional non-GMP pilot run
- cGMP scale-up options from 200 L to 1000 L